Hackensack University Medical Center
Edison, New Jersey, United States
Purpose
to support evaluation of the pharmacokinetics and efficacy of novel compounds or regimen in the TB Drug Accelerator (TBDA) discovery pipeline that contribute to the development of safer, simpler and shorter universal TB treatment regimen
Division
Global Health
Date
May 2026
Region Served
GLOBAL
Committed amount
$1,049,703
Grant topic
Tuberculosis
Duration (months)
36
Grantee location
Edison, New Jersey, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.